Stenocare AS (FRA:S7C) Total Liabilities: €0.38 Mil (As of Mar. 2026)


FRA:S7C Stenocare AS FRA:S7C
34 GF Score
Price €0.13
GF Value €0.29
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Stenocare AS Total Liabilities?

Stenocare AS FRA:S7C 34 Total Liabilities is €0.38 Mil as of Mar. 2026. GuruFocus rates FRA:S7C with a GF Score™ of 34/100 and a GF Value™ of €0.29 (Possible Value Trap). The stock has 4 warning signs investors should review.

Stenocare AS's Total Liabilities for the quarter that ended in Mar. 2026 was €0.38 Mil.

Stenocare AS's quarterly Total Liabilities declined from Sep. 2025 (€0.88 Mil) to Dec. 2025 (€0.42 Mil) and declined from Dec. 2025 (€0.42 Mil) to Mar. 2026 (€0.38 Mil).

Stenocare AS's annual Total Liabilities increased from Dec. 2023 (€1.65 Mil) to Dec. 2024 (€3.07 Mil) but then declined from Dec. 2024 (€3.07 Mil) to Dec. 2025 (€0.42 Mil).

Stenocare AS Total Liabilities Historical Data

* Premium members only.

The historical data trend for Stenocare AS's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stenocare AS Total Liabilities Chart

Stenocare AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 0.50 2.08 1.65 3.07 0.42

Stenocare AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.93 0.85 0.88 0.42 0.38
FRA:S7C
34GF Score
Stenocare AS FRA:S7C
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stenocare AS Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Stenocare AS's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.424+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.42

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1.693-1.268
=0.43

Stenocare AS's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.382+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.38

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=1.588-1.206
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €0.38 Mil mean?
Stenocare AS (FRA:S7C) has a Total Liabilities of €0.38 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Stenocare AS and its competitors.
Is Stenocare AS's Total Liabilities too high?
Stenocare AS's current Total Liabilities is €0.38 Mil. Overall, Stenocare AS has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Stenocare AS's Total Liabilities compare to ZTS and UTHR?
Stenocare AS's Total Liabilities of €0.38 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Stenocare AS and its competitors. Stenocare AS's current Total Liabilities is €0.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stenocare AS stock overvalued right now?
Based on GuruFocus' analysis, Stenocare AS (FRA:S7C) is currently considered Possible Value Trap. The stock's GF Value™ is €0.29, compared to a current price of €0.13 — trading 56.9% below its estimated fair value. The current Total Liabilities is €0.38 Mil. Stenocare AS's overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Stenocare AS (FRA:S7C), the current Total Liabilities is €0.38 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stenocare AS (FRA:S7C) Overvalued in 2026?

Based on GuruFocus' analysis, Stenocare AS stock appears to be undervalued. The current stock price of €0.13 is trading 56.9% below its estimated GF Value™ of €0.29. GuruFocus considers Stenocare AS to be Possible Value Trap.

Key valuation signals for FRA:S7C:

  • Total Liabilities: €0.38 Mil
  • GF Value™: €0.29 vs. price of €0.13 (56.9% below fair value)
  • GF Score™: 34/100 with 4 warning signs

No single metric tells the full story. See the FRA:S7C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stenocare AS Business Description

Other Exchanges STENO:Denmark
Address Lejrvej 9, Vaerlose, DNK, 93500
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway.
34GF Score

Get the complete analysis for FRA:S7C

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.13
Price
€0.29
GF Value